Cantitate/Preț
Produs

Silent Myocardial Ischemia: Proceedings of the Symposium on New Drugs and Devices October 15–16, 1987, Philadelphia, Pennsylvania: Developments in Cardiovascular Medicine, cartea 88

Editat de J. Morganroth, E. Neil Moore
en Limba Engleză Paperback – 22 ian 2012
Although some investigators have questioned the importance and even the existence of silent myocardial ischemia, documentation presented at this two day symposium leaves little doubt about its existence and importance. It has been estimated that about 3 million of the estimated 4 million angina sufferers in the United states have frequent episodes of silent myocardial ischemia. Although it is not possible to define how many Americans die due to silent ischemia, it has been suggested that the mortality rate may exceed hundreds of thousands of victims annually. Unfortunately, there still remains a lack of definitive information as to why some ischemic events are painless. Some suggest the concept that the location and size of the myocardium at jeopardy relates to pain, that the pain threshold varies from patient to patient or that there are neurological deficits in the myocardium of some patients with silent ischemia. Abnormalities in myocardial perfusion and function can occur without pain. An interesting observation presented by several investigators has been that when a coronary artery is occluded in man, no ischemic pain is perceived for the first 30 seconds. Only after a 30 second period or so of occlusion does angina occur. An even more confusing observation is that some 30 second periods of occlusion of the same vessel in the same patient results in angina while the next occlusion can be a totally silent event.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 107010 lei  6-8 săpt.
  Springer Us – 22 ian 2012 107010 lei  6-8 săpt.
Hardback (1) 107692 lei  6-8 săpt.
  Springer Us – 30 iun 1988 107692 lei  6-8 săpt.

Din seria Developments in Cardiovascular Medicine

Preț: 107010 lei

Preț vechi: 112642 lei
-5% Nou

Puncte Express: 1605

Preț estimativ în valută:
20486 21325$ 16865£

Carte tipărită la comandă

Livrare economică 31 ianuarie-14 februarie 25

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9781461289807
ISBN-10: 1461289807
Pagini: 260
Ilustrații: XIV, 242 p.
Dimensiuni: 155 x 235 x 14 mm
Greutate: 0.37 kg
Ediția:Softcover reprint of the original 1st ed. 1988
Editura: Springer Us
Colecția Springer
Seria Developments in Cardiovascular Medicine

Locul publicării:New York, NY, United States

Public țintă

Research

Cuprins

I Epidemiology, Pathophysiology, Classification.- 1. Epidemiology and prevalence of silent myocardial ischemia, and prognosis in asymptomatic patients.- 2. Pathophysiology of ischemia: Why are some episodes silent?.- 3. Myocardial ischemia as a useful functional indicator of risk in patients with coronary artery disease.- 4. The diagnostic and prognostic value of exercise ECG and radionuclide markers of ischemia in asymptomatic and symptomatic populations.- 5. An integrated clinical classification for ischemic heart disease: A combined assessment of severity of coronary disease, left ventricular function and myocardial ischemia.- Panel Discussion.- II Detection and Prognosis.- 6. Methods to detect ischemia using ambulatory (Holter) electrocardiography.- 7. The prognostic significance of silent myocardial ischemia during exercise testing.- 8. The role of radionuclide techniques in the evaluation of patients with silent myocardial ischemia.- Panel Discussion.- 9. Longitudinal (natural history) studies of silent myocardial ischemia.- 10. Silent myocardial ischemia and sudden cardiac death.- Panel Discussion.- IV Therapy and FDA Claims.- 11. Antianginal drug therapy for silent myocardial ischemia: Adrenergic blockers and calcium entry blockers.- 12. Therapy for silent ischemia: Nitrates.- 13. What are the FDA requirements to obtain a claim for the indication of silent ischemia?.- Panel Discussion.- V Combination Drug Therapy—FDA Issues.- 14. Combination drug therapy: What studies are required to obtain approval?.- Participant List.